CERN Accelerating science

Article
Title Biological effectiveness of antiproton annihilation
Author(s) Maggiore, C J (Pbar Medical, Newport Beach) ; Agazaryan, N (UCLA, Los Angeles (main)) ; Bassler, N (Aarhus U. (main)) ; Blackmore, E (TRIUMF) ; Beyer, G (Geneva, U. Medical Ctr.) ; De Marco, J J (UCLA, Los Angeles (main)) ; Doser, Michael (CERN) ; Gruhn, Charles R (Pbar Medical, Newport Beach) ; Holzscheiter, M H (Pbar Medical, Newport Beach) ; Ichioka, T (Aarhus U. (main)) ; Iwamoto, K S (UCLA, Los Angeles (main)) ; Knudsen, H V (Aarhus U. (main)) ; Landua, Rolf (CERN) ; McBride, W H (UCLA, Los Angeles (main)) ; Møller, S P (Aarhus U. (main)) ; Petersen, J (Aarhus Kommunehospital) ; Smathers, J B (UCLA, Los Angeles (main)) ; Skarsgard, L D (British Columbia Cancer Research, Vancouver) ; Solberg, T (UCLA, Los Angeles (main)) ; Uggerhøj, U (Aarhus U. (main)) ; Withers, H R (UCLA, Los Angeles (main)) ; Wouters, B G (U.Maastricht)
Publication 2004
In: Nucl. Instrum. Methods Phys. Res., B 214 (2004) 181-185
In: 8th International Conference on Low-Energy Antiproton Physics, Yokohama, Japan, 3 - 7 Mar 2003, pp.181-185
DOI 10.1016/S0168-583X(03)01781-6
Subject category Health Physics and Radiation Effects
Accelerator/Facility, Experiment CERN AD ; ACE AD-4
Abstract A new experiment, AD-4/ACE (antiproton cell experiment), has been approved by the CERN Research Board. The experiment is scheduled to begin taking data in June and continue through the 2003 run cycle. The experiment is designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in "biological dose" in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The background, description, and status of the experiment are given.

Corresponding record in: Inspire


 記錄創建於2005-02-02,最後更新在2016-06-30